focus -WSS

focus

author：leisure time 2025-10-01 21:24:34 - browse：3

Blood samples — Marion Berard/AFP/GettyImages

With the advent of disease-modifying Alzheimer’s drugs, everyone in the world of Alzheimer’s diagnostics is bracing for the crush.

Based on their ability to slow cognitive decline, the Eisai/Biogen drug Leqembi won full approval from the FDA this month, and donanemab by Eli Lilly could be approved by year end. Clinicians now have to decide which patients are most suitable for treatment, which means better Alzheimer’s tests need to be developed.

“There’s going to be capacity issues because there’s just not enough neurologists in the world to treat this pool of patients with Alzheimer’s disease at the moment,” said Mark Stearman, a senior international product manager at Roche focusing on Alzheimer’s diagnostics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Women's World Cup brings attention to abuse in soccer

WSS

Medicaid, Medicare dual

Superbugs, antibiotic resistance get scrutiny in congress

Ionis has late

Health tech startups drop sharply from 2021 highs

Mindstrong's demise and the future of mental health care

FDA seeks to regulate lab

entertainment

focus

knowledge

Virginia high school admissions case could be legal follow

Shingles, which affected Dianne Feinstein, is on the rise

Medicare proposal to cover medical devices draws a mixed reaction

Covid vaccines: Private market messier than government rollout

Cancer drug shortages should be causing more outrage

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

Hepatitis C has a cure — but many Americans still lack access to it

Listen: Who gets the credit for GLP

Trump demands the U.S. pay no more for drugs than other countries … again

Kaiser Permanente unions announce official strike date

hotspot

Inequities make cancer less preventable for women: report

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Blinken talks high

Antibody drugs appear effective. Now can we make enough of them?

The debate over Covid

Grail's uphill battle for Medicare to cover its cancer screening test

leisure time

explore

focus

entertainment